TRIVARX LTD — Investor Relations & Filings

TrivarX Ltd is a digital health company focused on the development and commercialization of screening and diagnostic technologies for mental health conditions. The company's core offering is the Sleep Analysis Management and Screening (SAMAS) platform, an AI-driven solution designed to identify biomarkers associated with Major Depressive Disorder (MDD). By utilizing proprietary algorithms to analyze sleep architecture and physiological data, the platform provides a non-invasive method for assessing mental health status. TrivarX aims to integrate its technology into clinical workflows to assist healthcare providers in early detection and objective monitoring of depressive symptoms. The company's research and development efforts prioritize the validation of digital biomarkers to improve diagnostic accuracy and patient outcomes in the mental health sector.